General Information of Drug Transporter (DT)
DT ID DTD0443 Transporter Info
Gene Name SLC6A11
Transporter Name Sodium- and chloride-dependent GABA transporter 3
Gene ID
6538
UniProt ID
P48066
Post-Translational Modification of This DT
Overview of SLC6A11 Modification Sites with Functional and Structural Information
Sequence
PTM type
X-Acetylation X-N-glycosylation X-Oxidation X-Phosphorylation X-Ubiquitination X: Amino Acid

Acetylation

  Lysine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC6A11 [1]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

583

Experimental Method

Co-Immunoprecipitation

Detailed Description

Acetylation at SLC6A11 Lysine 583 has the potential to affect its expression or activity.

N-glycosylation

  Asparagine

          3 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC6A11 [2]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

187

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC6A11 Asparagine 187 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC6A11 [2]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

190

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC6A11 Asparagine 190 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC6A11 [2]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

198

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC6A11 Asparagine 198 has the potential to affect its expression or activity.

Oxidation

  Cystine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC6A11 [3]

Role of PTM

Potential impacts

Modified Residue

Cystine

Modified Location

80

Experimental Method

Co-Immunoprecipitation

Detailed Description

Oxidation at SLC6A11 Cystine 80 has the potential to affect its expression or activity.

Phosphorylation

  Serine

          6 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC6A11 [4]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

21

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC6A11 Serine 21 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC6A11 [4]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

29

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC6A11 Serine 29 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC6A11 [4]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

30

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC6A11 Serine 30 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC6A11 [5]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

510

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC6A11 Serine 510 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence SLC6A11 [6]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

591

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC6A11 Serine 591 has the potential to affect its expression or activity.

  PTM Phenomenon 6

Have the potential to influence SLC6A11 [5]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

603

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC6A11 Serine 603 has the potential to affect its expression or activity.

  Threonine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC6A11 [7]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

274

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC6A11 Threonine 274 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC6A11 [6]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

592

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC6A11 Threonine 592 has the potential to affect its expression or activity.

Ubiquitination

  Lysine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC6A11 [8]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

13

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC6A11 Lysine 13 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC6A11 [8]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

617

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC6A11 Lysine 617 has the potential to affect its expression or activity.
References
1 The Ukrainian language in the medical environment. Its current status and the outlook. Lik Sprava. 1994 Mar-Apr;(3-4):133-7.
2 dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: S6A11_HUMAN)
3 A Quantitative Tissue-Specific Landscape of Protein Redox Regulation during Aging. Cell. 2020 Mar 5;180(5):968-983.e24.
4 Phosphoproteomic analysis identifies the tumor suppressor PDCD4 as a RSK substrate negatively regulated by 14-3-3. Proc Natl Acad Sci U S A. 2014 Jul 22;111(29):E2918-27.
5 Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
6 Quantitative global phosphoproteomics of human umbilical vein endothelial cells after activation of the Rap signaling pathway. Mol Biosyst. 2013 Apr 5;9(4):732-49.
7 iTRAQ labeling is superior to mTRAQ for quantitative global proteomics and phosphoproteomics. Mol Cell Proteomics. 2012 Jun;11(6):M111.014423.
8 Quantitative Analysis of the Brain Ubiquitylome in Alzheimer's Disease. Proteomics. 2018 Oct;18(20):e1800108.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.